The Role Of Fibroscan In Detecting Hepatic Fibrosis Induced By Methotrexate

1. Bohan, A. & Boyer, J.L. (2002). Mechanisms of hepatic transport of drugs: implications for cholestatic drug reactions. Semin Liver Dis, 22(2), 123-136. doi: 10.1055/s-2002-30099Search in Google Scholar

2. Dumitrascu D. (1997). Hepatic lesions induced by drugs.. In M. Grigorescu & O. Pascu (Eds), Clinical gastroenterology treaty, vol II (pp. 283-297). Bucharest : Technical Publishing House,.Search in Google Scholar

3. Farrel, G.C. (1995). Importance of drug-induced liver disease. In: G.C. Farrel (ed), Drug-Induced Liver Diseases (pp 29-41), Edinburgh: Churchill Livingstone.Search in Google Scholar

4. Hagenbuch, B. & Meier, P.J. (2004). Organic anion transporting polypeptides of the OATP/ SLC21 family: phylogenetic classification as OATP/ SLCO superfamily, new nomenclature and molecular/functional properties. Pflugers Arch, 447(5), 653-665. doi: 10.1007/s00424-003-1168-ySearch in Google Scholar

5. Keppler, D. & Konig, J. (1997). Hepatic canalicular membrane 5: Expression and localization of the conjugate export pump encoded by the MRP2 (cMRP/cMOAT) gene in liver. FASEB J, 11(7), 509-516.10.1096/fasebj.11.7.9212074Search in Google Scholar

6. Keppler, D. & Konig, J. (2000). Hepatic secretion of conjugated drugs and endogenous substances. Semin Liver Dis, 20(3), 265-272. doi: 10.1055/s-2000-9391Search in Google Scholar

7. Lecureur, V., Courtois, A., Payen, L., Verhnet, L., Guillouzo, A. & Fardel, O. (2000). Expression and regulation of hepatic drug and bile acid transporters. Toxicology, 153(1-3), 203-219.10.1016/S0300-483X(00)00315-2Search in Google Scholar

8. Lee, J. & Boyer, J.L. (2000). Molecular alterations in hepatocyte transport mechanisms in acquired cholestatic liver disorders. Semin Liver Dis, 20(3), 373-384. doi: 10.1055/s-2000-9390Search in Google Scholar